FDA requests removal of all ranitidine products from the market

1280 Zantac Recall

WASHINGTON, D.C. – The U.S. Food and Drug Administration announced on Wednesday that they are requesting manufacturers to remove all prescription and over-the-counter ranitidine drugs from the market immediately.

Officials say this is the latest step in an ongoing investigation of the contaminant N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). We’re told it has been determined that the impurity in some of these products increases over time and when stored at higher than room temperatures, and may result in consumer exposure to unacceptable levels of this impurity.

As a result of this immediate request, ranitidine products will not be available for new or existing prescriptions or over the counter use in the U.S.

Categories: Health, National/World